Rituximab-including combined modality treatment for primary thyroid lymphoma: An effective regimen for elderly patients (Thyroid (2014) 24, 6 (994-999))

Natsuko Watanabe, Hiroto Narimatsu, Jaeduk Yoshimura Noh, Yo Kunii, Koji Mukasa, Masako Matsumoto, Miho Suzuki, Kenichi Sekiya, Hidemi Ohye, Ai Yoshihara, Kenji Iwaku, Sakiko Kobayashi, Kaori Kameyama, Kazuhiko Kobayashi, Yoshitaka Nishikawa, Masahiro Kami, Kiminori Sugino, Koichi Ito

Research output: Contribution to journalComment/debate

Original languageEnglish
Number of pages1
JournalThyroid
Volume24
Issue number9
DOIs
Publication statusPublished - 2014 Sep 1

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Watanabe, N., Narimatsu, H., Noh, J. Y., Kunii, Y., Mukasa, K., Matsumoto, M., Suzuki, M., Sekiya, K., Ohye, H., Yoshihara, A., Iwaku, K., Kobayashi, S., Kameyama, K., Kobayashi, K., Nishikawa, Y., Kami, M., Sugino, K., & Ito, K. (2014). Rituximab-including combined modality treatment for primary thyroid lymphoma: An effective regimen for elderly patients (Thyroid (2014) 24, 6 (994-999)). Thyroid, 24(9). https://doi.org/10.1089/thy.2013.0523.cxn